Overall, these findings demonstrate that TREM-1 activation remodels innate and adaptive immune compartments in the Pan02 tumor, characterized by an expansion of activated CD8+ T cells while reducing immunosuppressive Tregs. The gene discussed is TREM1; the disease is neoplasm.